期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (1)
Background: Tissue filler injection is popular for tissue augmentation, but it is still not widely used for depressed scar correction because of the l......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (1)
Background:Treatment of androgenetic alopecia (AGA) with concurrent electrodynamic microneedling and 5% minoxidil may further stimulate hair growth. O......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (2)
Psoriasis vulgaris (PV) not only affects patients' skin health but also increases the risk of coronary heart disease and diabetes, which brings both p......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (3)
Introduction: The aim of our study was to investigate the therapeutic effect of Mesenchymal stem cell-derived exosomes (MSC-exs) on eczema mice model.......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (4)
Background Atopic dermatitis (AD) has been a hot research direction of dermatologists for a long time. However, the knowledge structures and theme tre......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (6)
Background Generalized pustular psoriasis (GPP) is a rare, severe, and sometimes fatal form of childhood psoriasis. The first line therapies include a......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (4)
Background: Atopic dermatitis (AD) is one of the serious global problems. There were wide concerns about whether Janus kinase (JAK) inhibitor was an a......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (1)
Objective: To compare the traditional treatment of minimally invasion surgery with the evolving treatments of microneedles radiofrequency and microwav......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (2)
Plantar warts are common cutaneous diseases on the sole caused by the human papillomavirus, with a high annual incidence rate of 14%. It often causes ......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (4)
Background Zinc has shown promise in the treatment of patients with viral warts in several clinical trials, but there is no consensus on its effective......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (3)
Objective There were some clinical studies on GLP-1R agonist liraglutide therapy for psoriasis patients with type 2 diabetes, but there is a lack of r......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (4)
Background Psoriasis is chronic incurable skin inflammation. The anti-inflammatory properties of mesenchymal stem cells (MSCs) have been put forward t......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (4)
Purpose This review article serves to assess the consistency of recommendations from guidelines on biologic agents for psoriasis, based on the quality......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (5)
Objective: The current study aimed to investigate the prognosis and treatment of primary cutaneous angiosarcoma (PCA) and primary subcutaneous angiosa......
期刊: JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (4)
Accumulated evidences support the fetus's intestinal flora unbalance is associated with the development of allergic diseases. Probiotic supplements in......